Skystar Bio-Pharmaceutical Co., Ltd. has opened an R&D center in Shanghai that will expand the company’s veterinary vaccine, medicine and microorganism business. Known as Shanghai Siqiang Biotechnology Co., Ltd., the 200 square meter facility is filled with modern equipment, also housing six chief researchers, four of whom are from the Chinese Academy of Agricultural Sciences. More details...

Stock Symbol: (OTCBB: SKBI)